The MILV custodian now owns 75% of the OS, and the float is only 290 Mil shares. Custodian can not and will sell the 75% to anyone but the buyers of MILV, which we know are bringing in a Biotech tech. They would IMHO, return them to the treasury in exchange for non-convertible voting Preferred shares, as a control block. Its the only thing that makes any sense.
Target is a dime IMHO based on the tech they are bringing according to earlier SEC fillings by the buyer
(0)
(0)
NDT Pharmaceuticals Inc. (NDTP) Stock Research Links